This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights CrowdStrike, Splunk, SoFi, ACM Research and Twilio
by Zacks Equity Research
CrowdStrike, Splunk, SoFi, ACM Research and Twilio are included in this blog.
ACM Research as the Bull of the Day and Clorox have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
ACM Research as the Bull of the Day and Clorox have been highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: ACM Research (ACMR)
by Daniel Laboe
A niche under-the-radar small-cap semiconductor player with an ideal concentrated exposure to Asia
A Technical Breakdown Of The S&P 500 Going Into January's CPI Reading
by Daniel Laboe
Fear surrounding inflation, monetary policy, and their combined implication on sustained demand have held the S&P 500 in a technically-bound trading range
Datadog (DDOG) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Datadog's (DDOG) fourth-quarter results are likely to reflect increased adoption of its cloud-based monitoring and analytics platform
Diodes (DIOD) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Diodes' (DIOD) fourth-quarter results are likely to reflect robust adoption of its products in the automotive and global manufacturing expansion strategy
Wall Street Analysts Think ACM Research, Inc. (ACMR) Could Surge 71%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 70.6% in ACM Research, Inc. (ACMR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Buy The Chip Dip!
by Daniel Laboe
The semiconductor sector is ripe with buying opportunities after the recent market dip and this earnings season should generate some robust springboard price-action for well-positioned chip stocks.
Buyers Come In With A Penchant For Growth After Short Market Correction
by Daniel Laboe
This week's riveting earnings line-up promises to be chalked full of enlightening quarterly reports from leading corporations across sectors
Is It Time To Buy High-Growth Stocks?
by Daniel Laboe
Has fear caused the stock market to overdo this high-growth correction?
Fed Chair Powell's Wait & See Monetary Approach Is Bullish For Stocks
by Daniel Laboe
The Federal Reserve demonstrated an intentional lack of clarity in its post-meeting statements with significant emphasis on the flexibility
Bet on These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Toyota Motor (TM), ACM Research (ACMR) and Vocera (VCRA) are well poised to gain.
How ACM Research (ACMR) Stock Stands Out in a Strong Industry
by Zacks Equity Research
ACM Research (ACMR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Be Greedy When Others Are Fearful
by Daniel Laboe
Don't let the fear-mongering "40-Year High" headlines scare you out of this market
Top Stock Picks For 2022
by Daniel Laboe
2022 is a stock pickers market and the recent dip provides us with some favorable pricing for these winning picks.
Earnings Estimates Moving Higher for ACM Research, Inc. (ACMR): Time to Buy?
by Zacks Equity Research
ACM Research, Inc. (ACMR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
How Much Upside is Left in ACM Research, Inc. (ACMR)? Wall Street Analysts Think 64%
by Zacks Equity Research
The consensus price target hints at a 64.4% upside potential for ACM Research, Inc. (ACMR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ACM Research, Inc. (ACMR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ACM Research, Inc. (ACMR) delivered earnings and revenue surprises of 60.00% and 1.28%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate ACM Research, Inc. (ACMR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ACM Research, Inc. (ACMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 7th
by Zacks Equity Research
BE, ACMR, GPOR, NFE, and MGLN have been added to the Zacks Rank #5 (Strong Sell) List on October 7, 2021
ACM Research, Inc. (ACMR) Q2 Earnings Lag Estimates
by Zacks Equity Research
ACM Research, Inc. (ACMR) delivered earnings and revenue surprises of -26.92% and 4.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate ACM Research, Inc. (ACMR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ACM Research, Inc. (ACMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ACM Research, Inc. (ACMR) Moves 13.4% Higher: Will This Strength Last?
by Zacks Equity Research
ACM Research, Inc. (ACMR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The Zacks Analyst Blog Highlights: ACM Research, Alto Ingredients, Cerence, GrowGeneration Corp and SiTime Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ACM Research, Alto Ingredients, Cerence, GrowGeneration Corp and SiTime Corp
These 5 Stocks Surged in the Past Week: Should You Buy?
by Sejuti Banerjea
It probably isn't a good idea to jump into stocks just because others are doing it. Do a rationality check instead.